Esperion Therapeutics

Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a new class of drugs that focus on a novel therapeutic approach called "HDL Therapy," which is based on the company's understanding of high-density lipoprotein, or HDL, function.